|
|
|
|
| Symbol(s): |
NOVA |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
NovaMed has a current Overall Rating of D (Negative). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| NovaMed has a current Overall Rating of D (Negative). Power Rating (29) is low; appreciation potential (28) is negative. Relative to the S&P 500 Composite, NovaMed Inc has neutral Growth/Value characteristics -- its appeal is likely to be to Capital Gain-oriented investors. NOVA is of average investment quality. NovaMed's current technical position is mixed. NovaMed's Power Rating is 29. Earnings estimate behavior for NOVA has been slightly negative recently. NovaMed's Offices of...
| | |
|
|
